To uncover the mission of GRO Biosciences Inc., one has to look no further than its name. The acronym stands for “genomically recoded organisms” and describes the way in which the Boston-based startup seeks to go beyond the standard 20 amino acids to rewrite the genomes of bacterial strains to produce therapeutics with improved profiles.
